A detailed history of Catalytic Wealth Ria, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Catalytic Wealth Ria, LLC holds 29,008 shares of AZN stock, worth $1.83 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares
29,008
Previous 27,100 7.04%
Holding current value
$1.83 Million
Previous $2.11 Billion 6.93%
% of portfolio
0.39%
Previous 0.42%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$76.67 - $87.62 $146,286 - $167,178
1,908 Added 7.04%
29,008 $2.26 Billion
Q2 2024

Jul 31, 2024

SELL
$66.81 - $80.83 $19,107 - $23,117
-286 Reduced 1.04%
27,100 $2.11 Billion
Q1 2024

May 10, 2024

BUY
$61.03 - $69.57 $69,208 - $78,892
1,134 Added 4.32%
27,386 $1.86 Billion
Q4 2023

Feb 12, 2024

BUY
$61.89 - $69.28 $1.62 Million - $1.82 Million
26,252 New
26,252 $1.77 Billion

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $196B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Catalytic Wealth Ria, LLC Portfolio

Follow Catalytic Wealth Ria, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Catalytic Wealth Ria, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Catalytic Wealth Ria, LLC with notifications on news.